Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects with Advanced Fibrosis & Compensated Cirrhosis

Trial Identifier: 201213
Sponsor: GlaxoSmithKline
Start Date: March 2015
Primary Completion Date: December 2020
Condition: Hepatitis B

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
China Beijing, China, 100050
China Beijing, China, 100044
China Beijing, China, 100069
China Chongqing, China, 400038
China Hangzhou, China, 310000
China Jinan, China, 250021
China Shanghai, China, 200040
China Shanghai, China, 201508
China Shanghai, China, 200025
China Taiyuan, China, 030001
China Xi'an, China, 710061
China Zhengzhou, China, 450000
China, Guangdong Guangzhou, Guangdong, China, 510060
China, Hubei wuhan, Hubei, China, 430022
China, Jiangsu Nanjing, Jiangsu, China, 210002
China, Jiangsu Nanjing, Jiangsu, China, 210003
China, Jilin Changchun, Jilin, China, 130000
China, Shanxi xian, Shanxi, China, 710038
China, Sichuan Chengdu, Sichuan, China, 610041